Loading insider details...
Beta
Latest Form 4 (May 22, 2026): Grant/Award of 671 ALNY shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 22, 2026 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 671 | n/a |
| May 12, 2025 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 775 | n/a |
| May 20, 2024 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 5,228 | n/a |
| May 19, 2023 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 3,454 | n/a |
| Feb 27, 2023 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Exercise/Conversion | 136 | n/a |
| May 20, 2022 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 5,153 | n/a |
| Feb 25, 2022 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 136 | n/a |
| Jul 19, 2021 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 4,032 | n/a |
| Jul 6, 2020 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 4,581 | n/a |